{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:34:25Z","timestamp":1791174865885,"version":"4.1.0"},"reference-count":29,"publisher":"Royal College of Psychiatrists","issue":"5","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":13057,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1982,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>A 10 week double blind study of 24 agoraphobics and 16 social phobics all on clomipramine compared the effect of adding tryptophan or placebo. Tryptophan did not potentiate the beneficial effect of clomipramine on phobic avoidance, phobic fears or the incidence of panic attacks. Neither was the presence of depression a factor of outcome.<\/jats:p>","DOI":"10.1192\/bjp.140.5.484","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T19:20:52Z","timestamp":1218568852000},"page":"484-490","source":"Crossref","is-referenced-by-count":39,"title":["Does Tryptophan Potentiate Clomipramine in the Treatment of Agoraphobic and Social Phobic Patients?"],"prefix":"10.1192","volume":"140","author":[{"given":"J. C.","family":"Pecknold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Appeltauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wrzesinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"S0007125000136414_ref23","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979265600"},{"key":"S0007125000136414_ref27","article-title":"Effects of iproniazid in depressive syndromes","volume":"i","author":"West","year":"1959","journal-title":"British Medical Journal"},{"key":"S0007125000136414_ref15","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.119.551.467"},{"key":"S0007125000136414_ref26","doi-asserted-by":"publisher","DOI":"10.1177\/00369330750200S113"},{"key":"S0007125000136414_ref2","article-title":"Double blind comparative study of clomipramine in obsessive neurosis","volume":"25","author":"Ananth","year":"1979","journal-title":"Current Therapeutic Research"},{"key":"S0007125000136414_ref21","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.136.2.161"},{"key":"S0007125000136414_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(60)73041-X"},{"key":"S0007125000136414_ref25","first-page":"99","article-title":"A clinical trial of clomipramine and diazepam in the treatment of phobic and obsessive illness","volume":"5","author":"Waxman","year":"1977","journal-title":"Journal of International Medical Research"},{"key":"S0007125000136414_ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1967.01730190120016"},{"key":"S0007125000136414_ref22","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780240079009"},{"key":"S0007125000136414_ref12","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.119.5.432"},{"key":"S0007125000136414_ref8","article-title":"Double-blind controlled study in phobias and obsessions","volume":"5","author":"Karabanow","year":"1977","journal-title":"Journal of International Medical Research"},{"key":"S0007125000136414_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(69)90013-2"},{"key":"S0007125000136414_ref16","article-title":"Potentiation of monoamine oxidase inhibitors by tryptophan","volume":"ii","author":"Pare","year":"1963","journal-title":"Lancet"},{"key":"S0007125000136414_ref29","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770270057005"},{"key":"S0007125000136414_ref17","first-page":"153","volume-title":"Phenomenology and Treatment of Anxiety","author":"Redmond","year":"1979"},{"key":"S0007125000136414_ref1","article-title":"Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders","volume":"5","author":"Amin","year":"1977","journal-title":"Journal of International Medical Research"},{"key":"S0007125000136414_ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770110112012"},{"key":"S0007125000136414_ref28","article-title":"Antidepressant action of tryptophan","volume":"ii","author":"Young","year":"1974","journal-title":"Lancet"},{"key":"S0007125000136414_ref3","article-title":"A large open multicenter trial of Clomipramine (Anafranil) in the management of phobic disorders","volume":"5","author":"Beaumont","year":"1977","journal-title":"Journal of International Medical Research"},{"key":"S0007125000136414_ref13","volume-title":"Psychopharmacology: A Generation of Progress","author":"Klein","year":"1978"},{"key":"S0007125000136414_ref4","article-title":"Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4, a-dimethylmeta-tyramine","volume":"5","author":"Carlsson","year":"1969","journal-title":"European Journal of Pharmacology"},{"key":"S0007125000136414_ref5","doi-asserted-by":"publisher","DOI":"10.1177\/00369330750200S112"},{"key":"S0007125000136414_ref20","doi-asserted-by":"publisher","DOI":"10.1177\/070674377301800106"},{"key":"S0007125000136414_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)91084-5"},{"key":"S0007125000136414_ref9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.116.533.387"},{"key":"S0007125000136414_ref10","doi-asserted-by":"publisher","DOI":"10.1007\/BF02193476"},{"key":"S0007125000136414_ref14","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.136.1.1"},{"key":"S0007125000136414_ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780140053006"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000136414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:24:49Z","timestamp":1558718689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000136414\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1982,5]]}},"alternative-id":["S0007125000136414"],"URL":"https:\/\/doi.org\/10.1192\/bjp.140.5.484","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,5]]}}}